{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:04:18Z","timestamp":1784156658914,"version":"3.55.0"},"reference-count":231,"publisher":"National Institute for Health and Care Research","issue":"38","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["13\/178\/01"],"award-info":[{"award-number":["13\/178\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title><jats:p>Tuberculosis (TB), caused by<jats:italic>Mycobacterium tuberculosis<\/jats:italic>(MTB) [(Zopf 1883) Lehmann and Neumann 1896], is a major cause of morbidity and mortality. Nearly one-third of the world\u2019s population is infected with MTB; TB has an annual incidence of 9 million new cases and each year causes 2 million deaths worldwide.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-2\"><jats:title>Objectives<\/jats:title><jats:p>To investigate the clinical effectiveness and cost-effectiveness of screening tests [interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs)] in latent tuberculosis infection (LTBI) diagnosis to support National Institute for Health and Care Excellence (NICE) guideline development for three population groups: children, immunocompromised people and those who have recently arrived in the UK from high-incidence countries. All of these groups are at higher risk of progression from LTBI to active TB.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-3\"><jats:title>Data sources<\/jats:title><jats:p>Electronic databases including MEDLINE, EMBASE, The Cochrane Library and Current Controlled Trials were searched from December 2009 up to December 2014.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-4\"><jats:title>Review methods<\/jats:title><jats:p>English-language studies evaluating the comparative effectiveness of commercially available tests used for identifying LTBI in children, immunocompromised people and recent arrivals to the UK were eligible. Interventions were IGRAs [QuantiFERON<jats:sup>\u00ae<\/jats:sup>-TB Gold (QFT-G), QuantiFERON<jats:sup>\u00ae<\/jats:sup>-TB Gold-In-Tube (QFT-GIT) (Cellestis\/Qiagen, Carnegie, VA, Australia) and T-SPOT.<jats:italic>TB<\/jats:italic>(Oxford Immunotec, Abingdon, UK)]. The comparator was TST 5\u2009mm or 10\u2009mm alone or with an IGRA. Two independent reviewers screened all identified records and undertook a quality assessment and data synthesis. A de novo model, structured in two stages, was developed to compare the cost-effectiveness of diagnostic strategies.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-5\"><jats:title>Results<\/jats:title><jats:p>In total, 6687 records were screened, of which 53 unique studies were included (a further 37 studies were identified from a previous NICE guideline). The majority of the included studies compared the strength of association for the QFT-GIT\/G IGRA with the TST (5\u2009mm or 10\u2009mm) in relation to the incidence of active TB or previous TB exposure. Ten studies reported evidence on decision-analytic models to determine the cost-effectiveness of IGRAs compared with the TST for LTBI diagnosis. In children, TST (\u2265\u20095\u2009mm) negative followed by QFT-GIT was the most cost-effective strategy, with an incremental cost-effectiveness ratio (ICER) of \u00a318,900 per quality-adjusted life-year (QALY) gained. In immunocompromised people, QFT-GIT negative followed by the TST (\u2265\u20095\u2009mm) was the most cost-effective strategy, with an ICER of approximately \u00a318,700 per QALY gained. In those recently arrived from high TB incidence countries, the TST (\u2265\u20095\u2009mm) alone was less costly and more effective than TST (\u2265\u20095\u2009mm) positive followed by QFT-GIT or T-SPOT.<jats:italic>TB<\/jats:italic>or QFT-GIT alone.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-6\"><jats:title>Limitations<\/jats:title><jats:p>The limitations and scarcity of the evidence, variation in the exposure-based definitions of LTBI and heterogeneity in IGRA performance relative to TST limit the applicability of the review findings.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-7\"><jats:title>Conclusions<\/jats:title><jats:p>Given the current evidence, TST (\u2265\u20095\u2009mm) negative followed by QFT-GIT for children, QFT-GIT negative followed by TST (\u2265\u20095\u2009mm) for the immunocompromised population and TST (\u2265\u20095\u2009mm) for recent arrivals were the most cost-effective strategies for diagnosing LTBI that progresses to active TB. These results should be interpreted with caution given the limitations identified. The evidence available is limited and more high-quality research in this area is needed including studies on the inconsistent performance of tests in high-compared with low-incidence TB settings; the prospective assessment of progression to active TB for those at high risk; the relative benefits of two-compared with one-step testing with different tests; and improved classification of people at high and low risk for LTBI.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-8\"><jats:title>Study registration<\/jats:title><jats:p>This study is registered as PROSPERO CRD42014009033.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-9\"><jats:title>Funding<\/jats:title><jats:p>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta20380","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T23:22:17Z","timestamp":1464132137000},"page":"1-678","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation"],"prefix":"10.3310","volume":"20","author":[{"given":"Peter","family":"Auguste","sequence":"first","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tsertsvadze","sequence":"additional","affiliation":[{"name":"Evidence in Communicable Disease Epidemiology and Control, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Pink","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Court","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Seedat","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gurung","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Freeman","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Taylor-Phillips","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Walker","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Madan","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngianga-Bakwin","family":"Kandala","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Information Sciences, Faculty of Engineering and Environment, Northumbria University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Clarke","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sutcliffe","sequence":"additional","affiliation":[{"name":"Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2016,5]]},"reference":[{"key":"key2016052010525521_ref1-bib1","volume-title":"Global Tuberculosis Report 2013","author":"World Health Organization","year":"2013"},{"key":"key2016052010525521_ref1-bib2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"key2016052010525521_ref1-bib3","first-page":"213","article-title":"Global tuberculosis incidence and mortality during 1990\u20132000","volume":"72","author":"Dolin","year":"1994","journal-title":"Bull World Health Organ"},{"key":"key2016052010525521_ref1-bib4","volume-title":"Tuberculosis in the UK: Report on Tuberculosis Surveillance and Control in the UK 2010","author":"Anderson","year":"2010"},{"key":"key2016052010525521_ref1-bib5","volume-title":"Tuberculosis in the UK: Annual Report on Tuberculosis Surveillance in the UK, 2013","author":"Pedrazzoli","year":"2013"},{"key":"key2016052010525521_ref1-bib6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(11)70069-X","article-title":"Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis","volume":"11","author":"Pareek","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key2016052010525521_ref1-bib7","volume-title":"Collaborative Tuberculosis Strategy for England 2014 to 2019: For Consultation","author":"Public Health England","year":"2014"},{"key":"key2016052010525521_ref1-bib8","volume-title":"Core Curriculum on Tuberculosis: What the Clinician Should Know","author":"Centers for Disease Control and Prevention","year":"2013","edition":"6th edn."},{"key":"key2016052010525521_ref1-bib9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/2046-0481-62-6-390","article-title":"An outbreak of tuberculosis affecting cattle and people on an Irish dairy farm, following the consumption of raw milk","volume":"62","author":"Doran","year":"2009","journal-title":"Ir Vet J"},{"key":"key2016052010525521_ref1-bib10","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control","author":"National Collaborating Centre for Chronic Conditions","year":"2011"},{"key":"key2016052010525521_ref1-bib11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key2016052010525521_ref1-bib12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/1817-1737.44778","article-title":"Diagnosis of latent tuberculosis: can we do better?","volume":"4","author":"Al-Orainey","year":"2009","journal-title":"Ann Thorac Med"},{"key":"key2016052010525521_ref1-bib13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/cid\/cir068","article-title":"Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection","volume":"52","author":"Herrera","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key2016052010525521_ref1-bib14","volume-title":"Tuberculosis: Factsheet 104","author":"World Health Organization","year":"2014"},{"key":"key2016052010525521_ref1-bib15","first-page":"1","article-title":"Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America","volume":"54","author":"Taylor","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key2016052010525521_ref1-bib16","first-page":"879","article-title":"Identification and management of latent tuberculosis infection","volume":"79","author":"Hauck","year":"2009","journal-title":"Am Fam Physician"},{"key":"key2016052010525521_ref1-bib17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/13557858.1997.9961823","article-title":"The epidemiology of tuberculosis by ethnic group in Birmingham and its implications for future trends in tuberculosis in the UK","volume":"2","author":"Bakhshi","year":"1997","journal-title":"Ethn Health"},{"key":"key2016052010525521_ref1-bib18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key2016052010525521_ref1-bib19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"key2016052010525521_ref1-bib20","volume-title":"Core Curriculum on Tuberculosis: What the Clinician Should Know","author":"Centers for Disease Control and Prevention","year":"2013","edition":"6th edn."},{"key":"key2016052010525521_ref1-bib21","first-page":"612","article-title":"Diagnostics for tuberculosis: global demand and market potential","volume":"369","author":"Cunningham","year":"2007","journal-title":"Lancet"},{"key":"key2016052010525521_ref1-bib22","volume-title":"Robbins Basic Pathology","author":"Kumar","year":"2007","edition":"8th edn."},{"key":"key2016052010525521_ref1-bib23","volume-title":"Tuberculosis: What You Need To Know","author":"US Department of Agriculture, Food Safety and Inspection Service","year":"1997"},{"key":"key2016052010525521_ref1-bib24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.279.12.943","article-title":"Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel","volume":"279","author":"Chaulk","year":"1998","journal-title":"JAMA"},{"key":"key2016052010525521_ref1-bib25","volume-title":"Treatment of Tuberculosis: Case Holding until Cure","author":"Chaulet","year":"1983"},{"key":"key2016052010525521_ref1-bib26","volume-title":"Drug-Resistant TB: Why It Matters","author":"GBC Health","year":"2011"},{"key":"key2016052010525521_ref1-bib27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","article-title":"Diagnostic standards and classification of tuberculosis in adults and children","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key2016052010525521_ref1-bib28","volume-title":"Public Health (Control of Disease) Act 1984","author":"Great Britain","year":"1984"},{"key":"key2016052010525521_ref1-bib29","volume-title":"UK Tuberculosis (TB) Surveillance Data","author":"Public Health England","year":"2014"},{"key":"key2016052010525521_ref1-bib30","article-title":"Statutory notifications of tuberculosis","volume":"14","author":"Health Protection Agency","year":"2004","journal-title":"Commun Dis Rep CDR Wkly"},{"key":"key2016052010525521_ref1-bib31","volume-title":"Total TB Cases and TB Notification Rates, 1995\u20132006, WHO European Region","author":"EuroTB","year":"2006"},{"key":"key2016052010525521_ref1-bib32","volume-title":"Migrant Health: Infectious Diseases in Non-UK Born Populations in England, Wales, and Northern Ireland. A Baseline Report \u2013 2006","author":"Health Protection Agency","year":"2006"},{"key":"key2016052010525521_ref1-bib33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0007-0971(84)90136-0","article-title":"Asian immigrant tuberculosis \u2013 the effect of visiting Asia","volume":"78","author":"McCarthy","year":"1984","journal-title":"Br J Dis Chest"},{"key":"key2016052010525521_ref1-bib34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/thx.2009.134247","article-title":"Diabetes and tuberculosis: a gathering storm?","volume":"65","author":"Moore-Gillon","year":"2010","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib35","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0140-6736(13)60910-1","volume":"381","author":"The Lancet. The ongoing problem of tuberculosis in the UK","year":"2013","journal-title":"Lancet"},{"key":"key2016052010525521_ref1-bib36","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S1473-3099(13)70276-7","article-title":"Tuberculosis rates unacceptably high in UK cities","volume":"13","author":"Kirby","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key2016052010525521_ref1-bib37","volume-title":"Migrants in the UK Overview","author":"Rienzo","year":"2013"},{"key":"key2016052010525521_ref1-bib38","volume-title":"Tuberculosis in London: Annual Review (2011 Data)","author":"Anderson","year":"2012"},{"key":"key2016052010525521_ref1-bib39","volume-title":"London: Census Profile","author":"Krausova","year":"2013"},{"key":"key2016052010525521_ref1-bib40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key2016052010525521_ref1-bib41","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLOS Pathog"},{"key":"key2016052010525521_ref1-bib42","first-page":"550","article-title":"HIV\u2013TB co-infection: epidemiology, diagnosis and management","volume":"121","author":"Sharma","year":"2005","journal-title":"Indian J Med Res"},{"key":"key2016052010525521_ref1-bib43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1258\/0956462053057576","article-title":"Co-infection with HIV and TB: double trouble","volume":"16","author":"McShane","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"3","key":"key2016052010525521_ref1-bib44","doi-asserted-by":"publisher","DOI":"10.3310\/hta11030","article-title":"A systematic review of rapid diagnostic tests for the detection of tuberculosis infection","volume":"11","author":"Dinnes","year":"2007","journal-title":"Health Technol Assess"},{"key":"key2016052010525521_ref1-bib45","volume-title":"Pulmonary Tuberculosis","author":"Vyas","year":"2013"},{"key":"key2016052010525521_ref1-bib46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1477-7525-2-58","article-title":"Factors influencing quality of life in patients with active tuberculosis","volume":"2","author":"Marra","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"key2016052010525521_ref1-bib47","volume-title":"Overcoming Tuberculosis: A Handbook for Patients","author":"Thorn","year":"2007"},{"key":"key2016052010525521_ref1-bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/00333549101250S407","article-title":"Tuberculosis and stigmatization: pathways and interventions","volume":"125","author":"Courtwright","year":"2010","journal-title":"Public Health Rep"},{"key":"key2016052010525521_ref1-bib49","volume-title":"The Facts about Tuberculosis","author":"Substance Abuse and Mental Health Services Administration","year":"1995"},{"key":"key2016052010525521_ref1-bib50","volume-title":"Case for Change: TB Services in London","year":"2011"},{"key":"key2016052010525521_ref1-bib51","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control","author":"National Collaborating Centre for Chronic Conditions, Centre for Clinical Practice at the National Institute for Health and Care Excellence","year":"2006"},{"key":"key2016052010525521_ref1-bib52","volume-title":"Identifying and Managing Tuberculosis among Hard-to-Reach Groups","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"key2016052010525521_ref1-bib53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1183\/09031936.06.00011806","article-title":"Cost-optimisation of screening for latent tuberculosis in close contacts","volume":"28","author":"Diel","year":"2006","journal-title":"Eur Respir J"},{"key":"key2016052010525521_ref1-bib54","first-page":"175","article-title":"Tuberculin test. Variability with the Mantoux procedure","volume":"132","author":"Chaparas","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"key2016052010525521_ref1-bib55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2105\/AJPH.75.11.1341","article-title":"A demonstration of lack of variability among six tuberculin skin test readers","volume":"75","author":"Perez-Stable","year":"1985","journal-title":"Am J Public Health"},{"key":"key2016052010525521_ref1-bib56","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"key2016052010525521_ref1-bib57","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"key2016052010525521_ref1-bib58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"key2016052010525521_ref1-bib59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key2016052010525521_ref1-bib60","doi-asserted-by":"crossref","first-page":"19373","DOI":"10.2807\/ese.14.43.19373-en","article-title":"Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers","volume":"14","author":"Girardi","year":"2009","journal-title":"Euro Surveill"},{"key":"key2016052010525521_ref1-bib61","volume-title":"Latent Tuberculosis Treatment with Rifapentine and Isoniazid by Directly Observed Therapy","author":"Ahitan","year":"2013"},{"key":"key2016052010525521_ref1-bib62","first-page":"1650","article-title":"Recommendations for use of an isoniazid\u2013rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key2016052010525521_ref1-bib63","volume-title":"Tuberculosis Prevention and Treatment: A Toolkit for Planning, Commissioning and Delivering High-Quality Services in England","author":"Department of Health","year":"2007"},{"key":"key2016052010525521_ref1-bib64","volume-title":"Health Clearance for Tuberculosis, Hepatitis B, Hepatitis C and HIV: New Healthcare Workers","author":"Department of Health","year":"2007"},{"key":"key2016052010525521_ref1-bib65","volume-title":"Stopping Tuberculosis in England: An Action Plan from the Chief Medical Officer","author":"Department of Health","year":"2004"},{"key":"key2016052010525521_ref1-bib66","volume-title":"The Interdepartmental Working Group on Tuberculosis: The Prevention and Control of Tuberculosis in the United Kingdom","author":"Department of Health","year":"1998"},{"key":"key2016052010525521_ref1-bib67","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/thx.2009.133173","article-title":"Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease","volume":"65","author":"British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee","year":"2010","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib68","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.57.4.289","article-title":"Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations","volume":"57","author":"British Thoracic Society Standards of Care Committee","year":"2002","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib70","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/thorax.55.3.210","article-title":"Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999","volume":"55","author":"Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society","year":"2000","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib71","volume-title":"Model of Care: TB Services in London","author":"London Health Programmes","year":"2011"},{"key":"key2016052010525521_ref1-bib72","first-page":"257","article-title":"Recent developments in treatment of latent tuberculosis infection","volume":"133","author":"Menzies","year":"2011","journal-title":"Indian J Med Res"},{"key":"key2016052010525521_ref1-bib73","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1155\/2013\/601737","article-title":"Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence","volume":"2013","author":"Trajman","year":"2013","journal-title":"Pulm Med"},{"key":"key2016052010525521_ref1-bib74","volume-title":"Latent TB Testing and Treatment for Migrants: A Practical Guide for Commissioners and Practitioners","author":"Public Health England","year":"2015"},{"key":"key2016052010525521_ref1-bib75","first-page":"S60","article-title":"IGRAs in public health practice: economic issues","volume":"14","author":"Kawamura","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib76","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"Landry","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib77","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2013","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib78","volume-title":"Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis among Individuals with, or at Risk of, Latent Tuberculosis Infection","author":"National Institute for Health Research","year":"2010"},{"key":"key2016052010525521_ref1-bib79","volume-title":"Tuberculosis Screening","author":"Public Health England","year":"2014"},{"key":"key2016052010525521_ref1-bib80","volume-title":"Tuberculosis (TB): An Epidemiological Analysis and Review of Service Provision in Hammersmith and Fulham, Kensington and Chelsea, and Westminster. Tri-Borough Joint Strategic Needs Assessment Report 2014","author":"Junghans","year":"2014"},{"key":"key2016052010525521_ref1-bib81","volume-title":"Tuberculosis Summary Needs Assessment. Leicester, Leicestershire and Rutland","author":"Theaker","year":"2013"},{"key":"key2016052010525521_ref1-bib82","volume-title":"Infectious Disease and Human Immunodeficiency Virus (HIV)","author":"Kirklees Joint Strategic Needs Assessment","year":"2014"},{"key":"key2016052010525521_ref1-bib83","volume-title":"Tuberculosis (TB)","author":"Manchester City Council Joint Strategic Needs Assessment","year":"2014"},{"key":"key2016052010525521_ref1-bib84","volume-title":"Birmingham and Solihull Tuberculosis Service: South and City Colleage Birmingham Tackles TB","author":"Dedicoat","year":"2014"},{"key":"key2016052010525521_ref1-bib85","volume-title":"TB Service","author":"Newcastle upon Tyne Hospitals NHS Foundation Trust"},{"key":"key2016052010525521_ref1-bib86","volume-title":"Tuberculosis.","author":"Birmingham and Solihull TB services"},{"key":"key2016052010525521_ref1-bib87","volume-title":"Tuberculosis (TB) Service 2014","author":"Liverpool Community Health NHS Trust"},{"key":"key2016052010525521_ref1-bib88","volume-title":"Diagnostics Assessment Programme Manual","author":"National Institute for Health and Care Excellence","year":"2011"},{"key":"key2016052010525521_ref1-bib89","volume-title":"Diagnostic Assessments Programme Manual","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"key2016052010525521_ref1-bib90","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"key2016052010525521_ref1-bib91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.prrv.2010.09.009","article-title":"Immune-based diagnostics for TB in children: what is the evidence?","volume":"12","author":"Ling","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"key2016052010525521_ref1-bib92","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jclinepi.2009.02.005","article-title":"A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard","volume":"62","author":"Reitsma","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key2016052010525521_ref1-bib93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11606-012-2031-7","article-title":"Chapter 9: options for summarizing medical test performance in the absence of a \u2018gold standard\u2019","volume":"27","author":"Trikalinos","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"50","key":"key2016052010525521_ref1-bib94","doi-asserted-by":"publisher","DOI":"10.3310\/hta11500","article-title":"Evaluation of diagnostic tests when there is no gold standard. A review of methods","volume":"11","author":"Rutjes","year":"2007","journal-title":"Health Technol Assess"},{"key":"key2016052010525521_ref1-bib95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key2016052010525521_ref1-bib96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ"},{"key":"key2016052010525521_ref1-bib97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-2-9","article-title":"Conducting systematic reviews of diagnostic studies: didactic guidelines","volume":"2","author":"Deville","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"key2016052010525521_ref1-bib98","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0895-4356(94)00099-C","article-title":"Meta-analytic methods for diagnostic test accuracy","volume":"48","author":"Irwig","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"key2016052010525521_ref1-bib99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2288-6-31","article-title":"Meta-DiSc: a software for meta-analysis of test accuracy data","volume":"6","author":"Zamora","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"key2016052010525521_ref1-bib100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1536867X0900900203","article-title":"metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression","volume":"9","author":"Harbord","year":"2009","journal-title":"Stata J"},{"key":"key2016052010525521_ref1-bib101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/2046-4053-2-71","article-title":"Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework","volume":"2","author":"Huguet","year":"2013","journal-title":"Syst Rev"},{"key":"key2016052010525521_ref1-bib102","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key2016052010525521_ref1-bib103","doi-asserted-by":"publisher","first-page":"e17984","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLOS ONE"},{"key":"key2016052010525521_ref1-bib104","doi-asserted-by":"crossref","first-page":"714","DOI":"10.26719\/2011.17.9.714","article-title":"Evaluation of an interferon-gamma release assay in young contacts of active tuberculosis cases","volume":"17","author":"Noorbakhsh","year":"2011","journal-title":"East Mediterr Health J"},{"key":"key2016052010525521_ref1-bib105","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/INF.0b013e3181cb45da","article-title":"Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia","volume":"29","author":"Adetifa","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key2016052010525521_ref1-bib106","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1542\/peds.2010-1725","article-title":"Comparing the tuberculin skin test and T-SPOT.TB blood test in children","volume":"127","author":"Cruz","year":"2011","journal-title":"Pediatrics"},{"key":"key2016052010525521_ref1-bib107","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5588\/ijtld.10.0555","article-title":"QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact","volume":"15","author":"Kasambira","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib108","first-page":"331","article-title":"Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa","volume":"15","author":"Mahomed","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib109","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/INF.0b013e318220c52a","article-title":"Interferon-release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age","volume":"30","author":"Pavic","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key2016052010525521_ref1-bib110","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.5588\/ijtld.12.0389","article-title":"Risk factors for Mycobacterium tuberculosis infection in Indonesian children living with a sputum smear-positive case","volume":"16","author":"Rutherford","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib111","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5588\/ijtld.11.0491","article-title":"QuantiFERON-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case","volume":"16","author":"Rutherford","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib112","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/07448481.2011.580029","article-title":"Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting","volume":"60","author":"Talbot","year":"2012","journal-title":"J Am Coll Health"},{"key":"key2016052010525521_ref1-bib113","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/INF.0b013e3181ebfe8a","article-title":"Whole blood interferon-release assay is a useful tool for the diagnosis of tuberculosis infection particularly among Bacille Calmette\u2013Gu\u00e9rin-vaccinated children","volume":"29","author":"Tsolia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key2016052010525521_ref1-bib114","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1471-2334-11-319","article-title":"Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection","volume":"11","author":"Elzi","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key2016052010525521_ref1-bib115","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1399-3062.2012.00765.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation","volume":"15","author":"Moon","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"key2016052010525521_ref1-bib116","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transplant"},{"key":"key2016052010525521_ref1-bib117","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2334-12-195","article-title":"Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis","volume":"12","author":"Anibarro","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key2016052010525521_ref1-bib118","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","article-title":"High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of quantiFERON-TB GOLD, ELISPOT, and tuberculin skin test","volume":"37","author":"Lee","year":"2009","journal-title":"Infection"},{"key":"key2016052010525521_ref1-bib119","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s10067-011-1771-9","article-title":"Interferon-\u03b3 release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea","volume":"30","author":"Chang","year":"2011","journal-title":"Clin Rheumatol"},{"key":"key2016052010525521_ref1-bib120","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/tid.12027","article-title":"QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB","volume":"15","author":"Ahmadinejad","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"key2016052010525521_ref1-bib121","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jiph.2013.02.002","article-title":"Comparison of the tuberculin skin test and Quanti-FERON-TB Gold In-Tube (QFT-G) test for the diagnosis of latent tuberculosis infection in dialysis patients","volume":"6","author":"Al Jahdali","year":"2013","journal-title":"J Infect Public Health"},{"key":"key2016052010525521_ref1-bib122","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1080\/13102818.2009.10817646","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for latent tuberculosis screening in hemodialysis patients","volume":"23","author":"Ates","year":"2009","journal-title":"Biotechnol Biotechnol Equip"},{"key":"key2016052010525521_ref1-bib123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.diagmicrobio.2010.12.020","article-title":"Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-release assay in patients considered for anti-tumor necrosis factor-alpha therapy","volume":"71","author":"Casas","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key2016052010525521_ref1-bib124","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/lt.22375","article-title":"Comparison of the 2-step tuberculin skin test and the quantiFERON-TB Gold In-Tube Test for the screening of tuberculosis infection before liver transplantation","volume":"17","author":"Casas","year":"2011","journal-title":"Liver Transpl"},{"key":"key2016052010525521_ref1-bib125","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/1471-2334-13-513","article-title":"Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia","volume":"13","author":"Chkhartishvili","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key2016052010525521_ref1-bib126","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1469-0691.2009.02949.x","article-title":"Validity of interferon-release assays for the diagnosis of latent tuberculosis in haemodialysis patients","volume":"16","author":"Chung","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key2016052010525521_ref1-bib127","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3899\/jrheum.130303","article-title":"Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-release assay results","volume":"40","author":"Costantino","year":"2013","journal-title":"J Rheumatol"},{"key":"key2016052010525521_ref1-bib128","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/TP.0b013e3182907073","article-title":"Contribution of interferon-release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation","volume":"95","author":"Hadaya","year":"2013","journal-title":"Transplantation"},{"key":"key2016052010525521_ref1-bib129","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/art.34382","article-title":"Interferon-release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis","volume":"64","author":"Hsia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key2016052010525521_ref1-bib130","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","article-title":"Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation","volume":"12","author":"Kim","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"key2016052010525521_ref1-bib131","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s15010-012-0291-0","article-title":"Comparison of the tuberculin skin test and interferon-release assay for the diagnosis of latent tuberculosis infection before kidney transplantation","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"key":"key2016052010525521_ref1-bib132","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.transproceed.2013.08.059","article-title":"Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation","volume":"45","author":"Kim","year":"2013","journal-title":"Transplant Proc"},{"key":"key2016052010525521_ref1-bib133","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1136\/annrheumdis-2011-200941","article-title":"Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-release assays under real-life conditions","volume":"71","author":"Kleinert","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key2016052010525521_ref1-bib134","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"key2016052010525521_ref1-bib135","doi-asserted-by":"publisher","first-page":"505171","DOI":"10.5402\/2011\/505171","article-title":"The performance of Quantiferon TB Gold In-Tube as a screening tool in paediatric rheumatology prior to initiation of infliximab: a single centre\u2019s experience","volume":"2011","author":"Maritsi","year":"2011","journal-title":"ISRN Rheumatol"},{"key":"key2016052010525521_ref1-bib136","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/thx.2009.124891","article-title":"Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden","volume":"65","author":"Mutsvangwa","year":"2010","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib137","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key2016052010525521_ref1-bib138","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10238-012-0192-7","article-title":"Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases","volume":"13","author":"Ramos","year":"2013","journal-title":"Clin Exp Med"},{"key":"key2016052010525521_ref1-bib139","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1399-3062.2009.00469.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients","volume":"12","author":"Seyhan","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"key2016052010525521_ref1-bib140","first-page":"1736","article-title":"Diagnostic value of an IFN-gamma ELISPOT assay to detect latent tuberculosis infection in hepatitis C patients","volume":"6","author":"Shen","year":"2012","journal-title":"Afr J Microbiol Res"},{"key":"key2016052010525521_ref1-bib141","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0961203310397966","article-title":"Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus","volume":"20","author":"Takeda","year":"2011","journal-title":"Lupus"},{"key":"key2016052010525521_ref1-bib142","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1128\/CVI.05299-11","article-title":"Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy","volume":"18","author":"Vassilopoulos","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key2016052010525521_ref1-bib143","first-page":"1209","article-title":"Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers","volume":"14","author":"Harstad","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib144","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik","year":"2010","journal-title":"Eur Respir J"},{"key":"key2016052010525521_ref1-bib145","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/thx.2009.127555","article-title":"A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children","volume":"65","author":"Lucas","year":"2010","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib146","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s15010-010-0015-2","article-title":"Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants","volume":"38","author":"Orlando","year":"2010","journal-title":"Infection"},{"key":"key2016052010525521_ref1-bib147","first-page":"369","article-title":"QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy","volume":"32","author":"Saracino","year":"2009","journal-title":"New Microbiol"},{"key":"key2016052010525521_ref1-bib148","doi-asserted-by":"publisher","first-page":"515","DOI":"10.5588\/ijtld.13.0840","article-title":"Latent tuberculous infection prevalence among paediatric contacts of drug-resistant and drug-susceptible cases","volume":"18","author":"Laniado-Laborin","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jinf.2014.02.019","article-title":"A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients","volume":"69","author":"Lee","year":"2014","journal-title":"J Infect"},{"key":"key2016052010525521_ref1-bib150","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5578\/tt.3552","article-title":"Comparison of QuantiFERON-TB Gold In-Tube test with tuberculin skin test in children who had no contact with active tuberculosis case","volume":"62","author":"Metin Timur","year":"2014","journal-title":"Tuberk Toraks"},{"key":"key2016052010525521_ref1-bib151","doi-asserted-by":"publisher","first-page":"e97992","DOI":"10.1371\/journal.pone.0097992","article-title":"Mycobacterium tuberculosis infection in young children: analyzing the performance of the diagnostic tests","volume":"9","author":"Perez-Porcuna","year":"2014","journal-title":"PLOS ONE"},{"key":"key2016052010525521_ref1-bib152","doi-asserted-by":"publisher","first-page":"e100267","DOI":"10.1371\/journal.pone.0100267","article-title":"Comparison of the tuberculin skin test and interferon gamma release assay for the screening of tuberculosis in adolescents in close contact with tuberculosis TB patients","volume":"9","author":"Song","year":"2014","journal-title":"PLOS ONE"},{"key":"key2016052010525521_ref1-bib153","doi-asserted-by":"publisher","first-page":"294963","DOI":"10.1155\/2014\/294963","article-title":"Added value of quantiFERON TB-Gold In-Tube for detecting latent tuberculosis infection among persons living with HIV\/AIDS","volume":"2014","author":"Souza","year":"2014","journal-title":"Biomed Res Int"},{"key":"key2016052010525521_ref1-bib154","doi-asserted-by":"publisher","first-page":"e105003","DOI":"10.1371\/journal.pone.0105003","article-title":"Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure","volume":"9","author":"Tieu","year":"2014","journal-title":"PLOS ONE"},{"key":"key2016052010525521_ref1-bib155","first-page":"26","article-title":"Concordance of the tuberculin skin test and T-SPOT\u00ae.TB test results in kidney transplant candidates","volume":"19","author":"Sherkat","year":"2014","journal-title":"J Res Med Sci"},{"key":"key2016052010525521_ref1-bib156","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1164\/rccm.200402-232OC","article-title":"Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts","volume":"170","author":"Brock","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key2016052010525521_ref1-bib157","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.diagmicrobio.2008.08.022","article-title":"The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in bacille Calmette\u2013Gu\u00e9rin vaccinated children","volume":"62","author":"Chun","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key2016052010525521_ref1-bib158","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/thx.2005.048033","article-title":"Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children","volume":"61","author":"Connell","year":"2006","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib159","doi-asserted-by":"publisher","first-page":"e2624","DOI":"10.1371\/journal.pone.0002624","article-title":"A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children","volume":"3","author":"Connell","year":"2008","journal-title":"PLOS ONE"},{"key":"key2016052010525521_ref1-bib160","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2466-9-41","article-title":"T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette\u2013Gu\u00e9rin vaccination","volume":"9","author":"Hansted","year":"2009","journal-title":"BMC Pulm Med"},{"key":"key2016052010525521_ref1-bib161","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jinf.2009.02.019","article-title":"Contact investigation in a primary school using a whole blood interferon-gamma assay","volume":"58","author":"Higuchi","year":"2009","journal-title":"J Infect"},{"key":"key2016052010525521_ref1-bib162","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1440-1843.2006.01000.x","article-title":"Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school","volume":"12","author":"Higuchi","year":"2007","journal-title":"Respirology"},{"key":"key2016052010525521_ref1-bib163","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1542\/peds.2007-3618","article-title":"Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test","volume":"123","author":"Lighter","year":"2009","journal-title":"Pediatrics"},{"key":"key2016052010525521_ref1-bib164","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1017\/s0950268807009831","article-title":"Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children","volume":"136","author":"Okada","year":"2008","journal-title":"Epidemiol Infect"},{"key":"key2016052010525521_ref1-bib165","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1128\/JCM.02411-05","article-title":"Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis","volume":"44","author":"Tsiouris","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key2016052010525521_ref1-bib166","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2334-8-65","article-title":"Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test","volume":"8","author":"Winje","year":"2008","journal-title":"BMC Infect Dis"},{"key":"key2016052010525521_ref1-bib167","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ijid.2008.03.005","article-title":"A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile","volume":"12","author":"Balcells","year":"2008","journal-title":"Int J Infect Dis"},{"key":"key2016052010525521_ref1-bib168","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir J"},{"key":"key2016052010525521_ref1-bib169","first-page":"1177","article-title":"Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers","volume":"11","author":"Cobanoglu","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib170","first-page":"1190","article-title":"Utility of QuantiFERON-TB Gold In-Tube testing for latent TB infection in HIV-infected individuals","volume":"11","author":"Jones","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib171","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","article-title":"Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals","volume":"175","author":"Luetkemeyer","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key2016052010525521_ref1-bib172","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib173","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"key":"key2016052010525521_ref1-bib174","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key2016052010525521_ref1-bib175","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1183\/09031936.06.00110205","article-title":"Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients","volume":"28","author":"Piana","year":"2006","journal-title":"Eur Respir J"},{"key":"key2016052010525521_ref1-bib176","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"key2016052010525521_ref1-bib177","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1378\/chest.08-2575","article-title":"Performance of tests for latent tuberculosis in different groups of immunocompromised patients","volume":"136","author":"Richeldi","year":"2009","journal-title":"Chest"},{"key":"key2016052010525521_ref1-bib178","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key2016052010525521_ref1-bib179","first-page":"1427","article-title":"QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study","volume":"13","author":"Shovman","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib180","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3899\/jrheum.081292","article-title":"Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases","volume":"36","author":"Soborg","year":"2009","journal-title":"J Rheumatol"},{"key":"key2016052010525521_ref1-bib181","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2334-9-15","article-title":"Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals","volume":"9","author":"Talati","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key2016052010525521_ref1-bib182","first-page":"1271","article-title":"Usefulness of enzyme-linked immunospot assay (ELISPOT) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment","volume":"35","author":"Vassilopoulos","year":"2008","journal-title":"J Rheumatol"},{"key":"key2016052010525521_ref1-bib183","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1378\/chest.07-1815","article-title":"Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients","volume":"133","author":"Brodie","year":"2008","journal-title":"Chest"},{"key":"key2016052010525521_ref1-bib184","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jinf.2007.02.004","article-title":"QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants","volume":"55","author":"Carvalho","year":"2007","journal-title":"J Infect"},{"key":"key2016052010525521_ref1-bib185","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1465-9921-7-77","article-title":"Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons","volume":"7","author":"Diel","year":"2006","journal-title":"Respir Res"},{"key":"key2016052010525521_ref1-bib186","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis","volume":"177","author":"Diel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key2016052010525521_ref1-bib187","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1128\/CVI.00463-06","article-title":"Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in army personnel","volume":"14","author":"Franken","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"key2016052010525521_ref1-bib188","first-page":"585","article-title":"Contribution of a IFN-gamma assay in contact tracing for tuberculosis in a low-incidence, high immigration area","volume":"138","author":"Janssens","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"key2016052010525521_ref1-bib189","first-page":"820","article-title":"Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis","volume":"13","author":"Kik","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib190","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00420-007-0212-1","article-title":"Evaluation of the interferon-gamma release assay in healthcare workers","volume":"81","author":"Nienhaus","year":"2008","journal-title":"Int Arch Occup Environ Health"},{"key":"key2016052010525521_ref1-bib191","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1128\/CVI.13.1.53-58.2006","article-title":"Comparison of a new ESAT-6\/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population","volume":"13","author":"Porsa","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"key2016052010525521_ref1-bib192","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2334-8-140","article-title":"School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay","volume":"8","author":"Winje","year":"2008","journal-title":"BMC Infect Dis"},{"key":"key2016052010525521_ref1-bib193","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2004-0809","article-title":"Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents","volume":"114","author":"Saiman","year":"2004","journal-title":"Pediatrics"},{"key":"key2016052010525521_ref1-bib194","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10198-013-0471-6","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"14","author":"Husereau","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"36","key":"key2016052010525521_ref1-bib195","doi-asserted-by":"publisher","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"},{"key":"key2016052010525521_ref1-bib196","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-alpha antagonist therapy","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"key2016052010525521_ref1-bib197","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03262207","article-title":"Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening","volume":"16","author":"Kowada","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"key2016052010525521_ref1-bib198","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/ndt\/gfs479","article-title":"Cost effectiveness of the interferon-release assay for tuberculosis screening of hemodialysis patients","volume":"28","author":"Kowada","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key2016052010525521_ref1-bib199","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jinf.2013.08.009","article-title":"Cost effectiveness of interferon-release assay for TB screening of HIV positive pregnant women in low TB incidence countries","volume":"68","author":"Kowada","year":"2014","journal-title":"J Infect"},{"key":"key2016052010525521_ref1-bib200","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.ajkd.2012.06.004","article-title":"Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children","volume":"61","author":"Laskin","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"key2016052010525521_ref1-bib201","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key2016052010525521_ref1-bib202","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1097\/MIB.0b013e31829f008f","article-title":"Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease","volume":"19","author":"Swaminath","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"key2016052010525521_ref1-bib203","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/thoraxjnl-2011-200933","article-title":"Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting","volume":"68","author":"Mandalakas","year":"2013","journal-title":"Thorax"},{"issue":"2","key":"key2016052010525521_ref1-bib204","doi-asserted-by":"crossref","DOI":"10.3310\/hta3020","article-title":"Handling uncertainty when performing economic evaluation of healthcare interventions","volume":"3","author":"Briggs","year":"1999","journal-title":"Health Technol Assess"},{"key":"key2016052010525521_ref1-bib205","volume-title":"Decision Making in Health and Medicine: Integrating Evidence and Values","author":"Hunink","year":"2001"},{"key":"key2016052010525521_ref1-bib206","volume-title":"The Human Mortality Database"},{"key":"key2016052010525521_ref1-bib207","volume-title":"Health Survey for England \u2013 2012","author":"Health and Social Care Information Centre","year":"2013"},{"key":"key2016052010525521_ref1-bib208","first-page":"138","article-title":"Chest radiographs and their reliability in the diagnosis of tuberculosis","volume":"44","author":"Kumar","year":"2005","journal-title":"JNMA J Nepal Med Assoc"},{"key":"key2016052010525521_ref1-bib209","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"key2016052010525521_ref1-bib210","volume-title":"What is the Cost-Effectiveness of Latent Tuberculosis Infection (LTBI) Treatment with Different Regimens?","author":"White","year":"2015"},{"key":"key2016052010525521_ref1-bib211","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1016\/j.apm.2013.01.039","article-title":"A mathematical model of tuberculosis transmission with heterogeneity in disease susceptibility and progression under a treatment regimen for infectious cases","volume":"37","author":"Okuonghae","year":"2013","journal-title":"Appl Math Model"},{"key":"key2016052010525521_ref1-bib212","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0272989X10369001","article-title":"Developing a tuberculosis transmission model that accounts for changes in population health","volume":"31","author":"Oxlade","year":"2011","journal-title":"Med Decis Making"},{"key":"key2016052010525521_ref1-bib213","first-page":"308","article-title":"Estimating tuberculosis case mortality in England and Wales, 2001\u20132002","volume":"12","author":"Crofts","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib214","volume-title":"NHS Reference Costs 2012 to 2013","author":"Department of Health","year":"2013"},{"key":"key2016052010525521_ref1-bib215","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/thorax.57.1.45","article-title":"Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless","volume":"57","author":"Bothamley","year":"2002","journal-title":"Thorax"},{"key":"key2016052010525521_ref1-bib216","volume-title":"NHS Electronic Drug Tariff: February 2015","author":"NHS Business Services Authority","year":"2015"},{"key":"key2016052010525521_ref1-bib217","volume-title":"Unit Costs of Health and Social Care 2013","author":"Curtis","year":"2013"},{"key":"key2016052010525521_ref1-bib218","volume-title":"Population and Migration Data Catalogue","author":"Office for National Statistics","year":"2014"},{"key":"key2016052010525521_ref1-bib219","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"key2016052010525521_ref1-bib220","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/MCP.0b013e32832a0adc","article-title":"T-cell interferon-release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings","volume":"15","author":"Dheda","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"key2016052010525521_ref1-bib221","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib222","doi-asserted-by":"publisher","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLOS ONE"},{"key":"key2016052010525521_ref1-bib223","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1086\/596735","article-title":"Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons","volume":"199","author":"Sarrazin","year":"2009","journal-title":"J Infect Dis"},{"key":"key2016052010525521_ref1-bib224","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"key2016052010525521_ref1-bib225","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/1756-185X.12098","article-title":"Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis","volume":"16","author":"Song","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"key2016052010525521_ref1-bib226","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key2016052010525521_ref1-bib227","doi-asserted-by":"publisher","first-page":"558","DOI":"10.5858\/arpa.2012-0198-RA","article-title":"Understanding sources of bias in diagnostic accuracy studies","volume":"137","author":"Schmidt","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key2016052010525521_ref1-bib228","volume-title":"World Health Organization (WHO) Estimates of Tuberculosis Incidence by Rate, 2012 (Sorted by Rate","author":"Public Health England","year":"2014"},{"key":"key2016052010525521_ref1-bib229","first-page":"878","article-title":"Diagnosis and treatment of tuberculosis in undocumented migrants in low or intermediate incidence countries","volume":"12","author":"Heldal","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key2016052010525521_ref1-bib230","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1183\/09031936.00042908","article-title":"Comparison of tuberculosis surveillance systems in low incidence industrialised countries","volume":"32","author":"Mor","year":"2008","journal-title":"Eur Respir J"},{"key":"key2016052010525521_ref1-bib231","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2013","edition":"66 ed."}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20380\/hta20380.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002416","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20380\/hta20380.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2003419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:48:33Z","timestamp":1692114513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta20380\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":231,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2016,5]]}},"alternative-id":["10.3310\/hta20380"],"URL":"https:\/\/doi.org\/10.3310\/hta20380","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}